MDCX Stock Analysis: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$1.19
-0.06 (-4.80%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 30, 2026
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MDCX is down 13.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MDCX is down 13.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $1.19, which is considered oversold relative to its 30-day fair value range of $1.37 to $1.61.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $1.14, while resistance sits at $1.48. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.03 (+1502.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $1.14, while resistance sits at $1.48. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.03 (+1502.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.37 -
$1.61
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding MDCX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 1502.6% below Wall St target ($20.03)
- WARNING: Recommendation downgraded due to -13.1% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.37 -
$1.61
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.14
Resistance Level
$1.48
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.06
Wall Street Target
$20.03
(+1502.6%)
Last updated: January 31, 2026 2:43 PM ET
Data refreshes hourly during market hours. Next update: 3:43 PM
Data refreshes hourly during market hours. Next update: 3:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1111 | 60 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$135 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$332 | 66 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$245 | 61 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$192 | 58 HOLD |
Advanced MDCX Option Strategies
Professional options setups generated by AI based on today's MDCX price and gamma walls.
